Click to Share
 
 
  1. Latest News
  2. Submit Press Release

biologics Press Releases

  + XML/RSS  



By Cambridge Healthtech Institute
Scientists from around the world will convene to share practical applications and case studies in protein & antibody engineering and novel biotherapeutics development.
By Cambridge Healthtech Institute
World-renowned thought leaders share insights & best practices, discover industry trends and find solutions to current challenges
By Cambridge Healthtech Institute
Over 1,200 biotherapeutics industry experts will convene at this annual event to share insight and perspective on the evolution of biologics, and the generation, characterization, and clinical application of proteins.
By NAPSRx
The FDA’s Fast Track program has been implemented to accelerate the development and review of drugs to treat serious conditions and fill an unmet medical need
By Cambridge Healthtech Institute
Discussions will include a variety of issues on how to expedite your biologic to the market safely by overcoming immunogenicity assessment challenges, adopting prediction and mitigation approaches, and selecting the right bioassay.
By marcus evans
Interview with Richard DiCicco, Chairman with Harvest Moon Pharmaceuticals, on key topics to be discussed at the upcoming marcus evans 7th Product & Pipeline Enhancement for Generics Conference, on July 30-31, 2014 in Alexandria, VA
By Carmell Therapeutics Corp.
Carmell Therapeutics, a company that is developing novel products manufactured from blood plasma, which naturally accelerate the healing of injured tissues, is pleased to announce that it has been awarded a Phase I Small Business Innovation Research...
By SMi Group Ltd
SMi Group Reports: representatives over 55 companies will meet in Iselin, NJ, to discuss the latest achievements in the pre-filled syringe marketplace, developments in drug stabilisation and material interactions.
By Cambridge Healthtech Institute
Driving Innovation Through New Targets, Effective Tools, Next-Gen and Alternate Delivery Technologies
By Cambridge Healthtech Institute
Overcoming Challenges in Injectable Drug Delivery via Breakthrough Delivery and Device Strategies
By BioCapacity On Demand, LLC
Co-Manufacturing Agreement between BioCapacity On Demand and Medical Coaches Reached
By Cambridge Healthtech Institute
Over 1,600 scientists will convene at this annual event to celebrate the evolution of biologics, and the generation, characterization, and clinical application of proteins.
By Cambridge Healthtech Institute
Ten fellowship award winners will receive a poster presentation slot and a discounted registration rate of $195.* Full-time graduate students and Ph.D. candidates should apply. The summit will take place on May 5-7, 2014 in Boston, MA.
By Cambridge Healthtech Institute
Shaping the Future of Delivering Biotherapeutics - What's on the Horizon
By smi group
SMi's Biosimilars: Commercial Strategies and Regulatory Guidelines masterclass, taking place on the 9 December in London, will address the common pitfalls in and around biosimilar regulatory requirements in both Europe and the US.
By Cambridge Healthtech Institute
New programs focused on “Antibody Optimization and Development” and “Manufacturing and Facilities” added to PepTalk 2014
By Cambridge Healthtech Institute
Dr. Lathey sits down with conference producer Samantha Lewis to discuss the biggest challenges to managing bioassay variability, tools and strategies that researchers are using to combat it, and how procedural variation can have unwanted effects.
By K2M Spine
The launch of this new addition to the VESUVIUS product family demonstrates K2M’s continued focus on growing our presence in the biologics market
By Cambridge Healthtech Institute
Chemical Computing Group will host a dinner short course in Boston, MA, on June 19, 2013, from 6:00-8:00 pm, on the conclusion of day one of CHI/Bio-IT World’s 13th annual Structure-Based Drug Design (SBDD) conference taking place at the Revere Hotel...
By SMi Group
Variations in global regulatory strategy for biosimilars outside Europe, Japan and the US

All Press Releases

By SMi Group
SMi's 6th annual Biosimilars and Biobetters conference, taking place on 30th September - 1st October 2015 in London, will cover regulatory updates, pharmacovigilance of biosimilars, patent litigation, market access and global market developments.
By Immune Response BioPharma, Inc.
(PR.com)-- Immune Response BioPharma, Inc., today provides an update on Remune and announces the FDA has accepted the Remune HIV/AIDS vaccine BLA (biologics licensing application) for review for therapeutic treatment in adults with HIV/AIDS.
By Cambridge Healthtech Institute
Scientists from around the world will convene to share practical applications and case studies in protein & antibody engineering and novel biotherapeutics development.
By Immune Response BioPharma
Immune Response BioPharma, Inc. Announces REMUNE FDA BLA Assignment PDUFA Goal date of December 22nd 2015 for Therapeutic HIV/AIDS Vaccine
By Cambridge Healthtech Institute
World-renowned thought leaders share insights & best practices, discover industry trends and find solutions to current challenges
By Cambridge Healthtech Institute
Over 1,200 biotherapeutics industry experts will convene at this annual event to share insight and perspective on the evolution of biologics, and the generation, characterization, and clinical application of proteins.
By NAPSRx
The FDA’s Fast Track program has been implemented to accelerate the development and review of drugs to treat serious conditions and fill an unmet medical need
By Cambridge Healthtech Institute
Discussions will include a variety of issues on how to expedite your biologic to the market safely by overcoming immunogenicity assessment challenges, adopting prediction and mitigation approaches, and selecting the right bioassay.
By marcus evans
Interview with Richard DiCicco, Chairman with Harvest Moon Pharmaceuticals, on key topics to be discussed at the upcoming marcus evans 7th Product & Pipeline Enhancement for Generics Conference, on July 30-31, 2014 in Alexandria, VA
By Carmell Therapeutics Corp.
Carmell Therapeutics, a company that is developing novel products manufactured from blood plasma, which naturally accelerate the healing of injured tissues, is pleased to announce that it has been awarded a Phase I Small Business Innovation Research...
By SMi Group Ltd
SMi Group Reports: representatives over 55 companies will meet in Iselin, NJ, to discuss the latest achievements in the pre-filled syringe marketplace, developments in drug stabilisation and material interactions.
By Cambridge Healthtech Institute
Driving Innovation Through New Targets, Effective Tools, Next-Gen and Alternate Delivery Technologies
By Cambridge Healthtech Institute
Overcoming Challenges in Injectable Drug Delivery via Breakthrough Delivery and Device Strategies
By BioCapacity On Demand, LLC
Co-Manufacturing Agreement between BioCapacity On Demand and Medical Coaches Reached
By Cambridge Healthtech Institute
Over 1,600 scientists will convene at this annual event to celebrate the evolution of biologics, and the generation, characterization, and clinical application of proteins.
By Cambridge Healthtech Institute
Ten fellowship award winners will receive a poster presentation slot and a discounted registration rate of $195.* Full-time graduate students and Ph.D. candidates should apply. The summit will take place on May 5-7, 2014 in Boston, MA.
By Cambridge Healthtech Institute
Shaping the Future of Delivering Biotherapeutics - What's on the Horizon
By BRDG Park
Combination of biologicals and big data creates opportunities for investors
By smi group
SMi's Biosimilars: Commercial Strategies and Regulatory Guidelines masterclass, taking place on the 9 December in London, will address the common pitfalls in and around biosimilar regulatory requirements in both Europe and the US.
By Cambridge Healthtech Institute
New programs focused on “Antibody Optimization and Development” and “Manufacturing and Facilities” added to PepTalk 2014
By Cambridge Healthtech Institute
Dr. Lathey sits down with conference producer Samantha Lewis to discuss the biggest challenges to managing bioassay variability, tools and strategies that researchers are using to combat it, and how procedural variation can have unwanted effects.
By K2M Spine
The launch of this new addition to the VESUVIUS product family demonstrates K2M’s continued focus on growing our presence in the biologics market
By Cambridge Healthtech Institute
Chemical Computing Group will host a dinner short course in Boston, MA, on June 19, 2013, from 6:00-8:00 pm, on the conclusion of day one of CHI/Bio-IT World’s 13th annual Structure-Based Drug Design (SBDD) conference taking place at the Revere Hotel...
By ThermoPod
Slim, trim thermal packaging liners save up to 70% on shippers' pallets + shelves compared to foam packaging and coolers, enabling better control of storage requirements. And unlike with foam packaging, the liners are disposable in ordinary trash.
By SMi Group
Variations in global regulatory strategy for biosimilars outside Europe, Japan and the US
By visiongain
A new report by visiongain, a London-based business information company, predicts that global revenues for biosimilars will reach $1.6 billion in 2012.
By Cambridge Healthtech Institute
Those that missed last month's event can get a CD with 350 speaker presentations from 16 conferences within 4 scientific channels: diagnostics, drug discovery & development, informatics and cancer. TriConference.com
By Report Buyer
New report: Regulatory Intelligence on Biologics Recalls: Immunoglobulins and Vaccines are Involved in More Recalls than Other Drug Classes
By Cambridge Healthtech Institute
Those that missed last month's event can get a CD with 80 speaker presentations from 4 pipelines: formulation, purification, biotherapeutics, and expression. Individual track CDs and the overall event CD is available at CHI-PepTalk.com.
By Frost & Sullivan
Seamlessly Integrated R&D, Production, Sales and Marketing Processes to Ensure Success in this High Growth Market
By Impuls Public Relations OG
Vela Laboratories and Anagnostics enter strategic partnership to offer hybcell technology to biotech and pharma customers under GMP conditions.
By George Colberg
Kalos Therapeutics, Inc. Co Founder George Colberg to Present at BIOCOM's Global Life Science Partnering Conference 2012, La Jolla, CA, USA,Thursday February 2nd, 2012 Being held at the Lodge at Torrey Pines in La Jolla CA
By Cambridge Healthtech Institute
100+ pharma and biotech companies from around the world will participate at CHI's 4th annual Integrated R&D Informatics & Knowledge Management conference to be held in San Francisco, CA on February 21-23, 2012.
By Cambridge Healthtech Institute
Dr. Leach will participate in a keynote session at this conference scheduled for Feb. 21-23, 2012, San Francisco, CA. The conference is organized by Cambridge Healthtech Institute.
By Cambridge Healthtech Institute
CHI’s Cancer Biologics conference is being held at the Molecular Med TRI-CON 2012 on February 21-23 at the Moscone in San Francisco.
By Industry Experts
A new global market report on 'Orthopedic Implants' has been released by Industry Experts. According to the report, the global market for orthopedic implants is projected to reach US$ 46.5 billion by 2017 from an estimated US$ 21.1 billion in 2007.
By Joe Walsh
Piribo, the online destination for Pharma intelligence, has added a new report.
By Harrisburg University of Science and Technology
Harrisburg University will host a panel “Biologics and Biosimilars” that will bring together key PA-based stakeholders—patient groups, physicians, opinion leaders and the bioscience community—to facilitate a policy discussion on biosimilars.
By IQPC
Within the next five years, the global biologics market is set to exceed $239 billion (£145 billion) in value, according to recent research by Bharat Book.
By Kalorama Information
French and American governments have implemented 2009-2011 tax incentives for drug developers or manufacturers, which bode well for the biopharmaceutical market worldwide, according to healthcare market research firm Kalorama Information in its...
By Fast Market Research
New Healthcare market report from Datamonitor: "R&D Trends: Psoriasis - Pipeline outlook following withdrawal of key regulatory filing"
By Fast Market Research
Recently published research from Datamonitor, "Pharmaceutical Key Trends 2011 - Biosimilar Market Overview", is now available at Fast Market Research
By American Conference Institute
A Primer on IP Basics and Regulatory Fundamentals Relative to Small Molecules and Biologics
By Masha Skvirtchak
We are less than two months away from a must attend educational and networking event for scientific and business leaders involved in drug delivery and formulation to discuss the current challenges and new strategies to succeed in this evolving area.
By Karen Cristino
With cancer costs projected to rise substantially over the next decade, J.P. Farley Corporation is providing their customers in cancer care treatment programs with financial savings.
By Fast Market Research
Fast Market Research recommends "The Global Market for Orthobioligical Products" from Espicom Business Intelligence, now available
By Aarkstore Enterprise
Aarkstore.com announce a new report "Global Biosimilars (Follow-on biologics) Market: An Analysis " through its vast collection of market research report.
By Kalos Therapeutics, Inc.
KT-220 will continue in development under the Qualifying Therapeutic Discovery Project (QTDP) program included in the Patient Protection and Affordable Health Care Act of 2010.
By Bharatbook
Bharatbook added a new report on "Multiple Sclerosis (MS) Drugs and Biologics: Technologies and Global Markets" into its market report catalogue for reselling.
By Kalorama Information
Breast cancer accounts for approximately 12% of all cancers worldwide. In the U.S. more than 200,000 people develop breast cancer each year, with more than 95% of these women.


Page:

Page updated every 10 minutes


Like PRLog?
9K2K1K
Click to Share